Xenon Pharmaceuticals Inc (XENE)
$37.41 -0.35% Close Oct 30, 2026 Live
Xenon Pharmaceuticals stock today
Xenon Pharmaceuticals closed at $37.41 on October 30, 2026, down 0.35% on the day. Over the past year it returned -12.3% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $3.62 billion.
$40.00$60.00
NovJan 2026MarMayJulSep
| Period | XENE | S&P 500 (SPY) |
|---|---|---|
| 1 month | +0.6% | -0.9% |
| 3 months | -41.7% | +2.1% |
| Year to date | -16.5% | +11.7% |
| 1 year | -12.3% | +12.4% |
| 3 years | +18.8% | +88.5% |
| 5 years | +20.1% | +76.0% |
Key statistics
- Market value
- $3.62B
- 52-week range
- $33.49 to $70.96
- Next report
- Nov 2, 2026
About Xenon Pharmaceuticals
Develops pharmaceutical treatments for neurological and psychiatric disorders.
Sector: Health Care
More on Xenon Pharmaceuticals
- Financials: revenue, earnings and segmentsRevenue -21% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $4,590 today
No forecast, no recommendation. This page describes Xenon Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.